Patents
Sitemap › C40 - Combinatorial technology › C40B - Combinatorial chemistry; Libraries, e.g. chemical libraries, in silico libraries › C40B 30 - Methods of screening libraries
Patents for C40B 30 - Methods of screening libraries (11,320)
06/2012
06/28/2012US20120165213 Methods, Reagents and Kits for Flow Cytometric Immunophenotyping
06/28/2012US20120165212 Method for the detection of gene transcripts in blood and uses thereof
06/28/2012US20120165211 Human Antibodies Cross-Reacting With A Bacterial And A Self Antigen From Atherosclerotic Plaques
06/28/2012US20120165210 Rapid genotyping analysis and the method thereof
06/28/2012US20120165209 Methods and compositions for directed microwave chemistry
06/28/2012US20120165208 method for predicting the responsiveness of a patient to a treatment with an anti-cd20 antibody and a method for diagnosing rheumatoid arthritis
06/28/2012US20120165207 Methods for Monitoring Allograft Rejection
06/28/2012US20120165206 Method and Assay for Glycosylation Pattern Detection Related to Cell State
06/28/2012US20120165205 Method for sequencing a polynucleotide template
06/28/2012US20120164693 Methods of enzymatic discrimination enhancement and surface-bound double-stranded dna
06/28/2012US20120164673 Ptp1b inhibitors
06/28/2012US20120164180 Cancer Vaccines and Therapeutic Methods
06/28/2012US20120164165 Zona pellucida binding peptides, expression vectors, compositions, and methods for species-specific immunocontraception of animals
06/28/2012US20120164161 Antibodies and Uses Thereof
06/28/2012US20120164074 Methods of diagnosing, preventing and treating cancer metastasis
06/27/2012EP2468767A2 Structure of the insulin receptor ectodomain
06/27/2012EP2468766A2 Structure of the insulin receptor ectodomain
06/27/2012EP2467483A1 Dna ligands for aflatoxin and zearalenone
06/27/2012CN101914527B Structural nucleic acid guided chemical synthesis
06/26/2012US8207324 Array of nucleotidic sequences for the detection and identification of genes that codify proteins with activities relevant in biotechnology present in a microbiological sample, and method for using this array
06/26/2012CA2425602C Methods of high-throughput screening for internalizing antibodies
06/21/2012WO2012058531A3 Modulation of response regulators by imidazole derivatives
06/21/2012US20120159672 Sequence-determined DNA fragments and corresponding polypeptides encoded thereby
06/21/2012US20120159660 Desaturases and methods of using them for synthesis of polyunsaturated fatty acids
06/21/2012US20120157542 Method to assess prognosis and to predict therapeutic success in cancer by determining hormone receptor expression levels
06/21/2012US20120157474 Methods of Identifying and Using General or Alternative Splicing Inhibitors
06/21/2012US20120157375 Identification of Inhibitors of a Bacterial Stress Response
06/21/2012US20120157345 Methods and Compositions for Obtaining and Using Biologically Active Multi-Protein Complexes
06/21/2012US20120157344 Gene expression signature for classification of kidney tumors
06/21/2012US20120157343 System and Methods to Quantify and Amplify Both Signaling and Probes for cDNA Chips and Gene Expression Microarrays
06/21/2012US20120157342 Predictive biomarkers useful for cancer therapy mediated by a wee1 inhibitor
06/21/2012US20120157341 Detection of digestive organ cancer, gastric cancer, colorectal cancer, pancreatic cancer, and biliary tract cancer by gene expression profiling
06/21/2012US20120157340 Pathways characterization of cells
06/21/2012US20120157339 Molecular Markers and Assay Methods for Characterizing Cells
06/21/2012US20120157338 Method for determining the risk of developing brain metastasis, and a kit to carry out said method
06/21/2012US20120157337 miRNA FINGERPRINT IN THE DIAGNOSIS OF MULTIPLE SCLEROSIS
06/21/2012US20120157336 miRNA FINGERPRINT IN THE DIAGNOSIS OF DISEASES
06/21/2012US20120157335 Flap Endonuclease-1 As A Marker For Cancer
06/21/2012US20120157334 Mirnas as biomarkers for distinguishing benign from malignant thyroid neoplasms
06/21/2012US20120157333 Oligonucleotides useful for detecting and analyzing nucleic acids of interest
06/21/2012US20120157332 Reagent Storage in an Assay Device
06/21/2012US20120157331 Methods of detecting susceptibility to leukemia/ lymphoma and induction of leukemia and lymphomas
06/21/2012US20120157330 Trenched Sample Assembly for Detection of Analytes with Electromagnetic Read-Write Heads
06/21/2012US20120157329 Method and Device for the in Vitro Analysis for MRNA of Genes Involved in Haematological Neoplasias
06/21/2012US20120157328 Label Free Kinase Assays and Reagents
06/21/2012US20120157327 Labelling Strategies for the Sensitive Detection of Analytes
06/21/2012US20120157326 Stem accelerated isothermal nucleic acid amplification technology
06/21/2012US20120157323 Two-hybrid based screen to identify disruptive residues at multiple protein interfaces
06/21/2012US20120156140 Fluorescent compounds
06/21/2012US20120156134 Compositions and methods for detecting or eliminating senescent cells to diagnose or treat disease
06/20/2012EP2466504A1 Protein-Protein interactions for pharmacological profiling
06/20/2012EP2465870A1 Binding polypeptides with diversified and consensus VH/VL hypervariable sequences
06/20/2012CN101538613B Molecular probe related to disease and method for producing the same
06/19/2012US8202823 Structural nucleic acid guided chemical synthesis
06/19/2012CA2530287C Enzyme-catalyzed metal deposition for the enhanced in situ detection of immunohistochemical epitopes and nucleic acid sequences
06/19/2012CA2406104C System for functional gene discovery in plants
06/14/2012WO2012078365A2 Biomarkers for prediction of breast cancer
06/14/2012US20120151612 Non-surgical approach to prevent and correct craniofacial malformations during development
06/14/2012US20120150032 Sequence Variants Associated with Prostate Specific Antigen Levels
06/14/2012US20120149668 Glucocorticoid receptor alleles and uses thereof
06/14/2012US20120149599 Combined rapid susceptibility assay and microorganism identification system
06/14/2012US20120149598 Feeder cells for target cell induction
06/14/2012US20120149597 Protein fragment complementation assays for high-throughput and high-content screening
06/14/2012US20120149596 Methods for assessing atherogenesis by determining oxidized phospholipid to apolipoprotein b ratios
06/14/2012US20120149595 Markers for diagnosis of pulmonary inflammation and methods related thereto
06/14/2012US20120149594 Biomarkers for prediction of breast cancer
06/14/2012US20120149593 Methods and arrays for profiling dna methylation
06/14/2012US20120149592 Compositions And Methods For Assessing Cytotoxicity Of Single Cells
06/14/2012US20120149591 In vitro peptide expression library
06/14/2012US20120149590 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore
06/14/2012US20120149589 Epigentic Markers Associated with Substance Use Disorders
06/14/2012US20120149588 Phased Genome Sequencing
06/14/2012US20120149587 Method for detecting nucleated cells
06/14/2012US20120149586 Methods of predicting the risk of recurrence of cancer
06/14/2012US20120149585 Compensator for multiple surface imaging
06/14/2012US20120148574 Diagnostic Markers for Ankylosing Spondylitis
06/14/2012US20120148491 Method of overcoming therapeutic limitations of nonuniform distribution of radiopharmaceuticals and chemotherapy drugs
06/14/2012CA2820908A1 Truncated her2 srm/mrm assay
06/14/2012CA2761559A1 Method and kit for the classification and prognosis of chronic wounds
06/13/2012EP2462435A2 Identification and use of compounds for treating persistent pain
06/13/2012EP2462246A1 Rapid establishment and/or termination of substantial steady-state drug delivery
06/07/2012WO2012074550A2 Methods to assess treatment outcomes in reward deficiency syndrome (rds) behaviors utilizing expression profiling
06/07/2012WO2012074473A1 Screening method
06/07/2012WO2012071665A1 Prognostic markers of inherited variations in the ugt2b genes for prostate cancer recurrence
06/07/2012WO2011060528A8 Heteropeptides useful for reducing nonspecific adsorption
06/07/2012US20120144510 Treatment of astrocytes-tumor cells inhibitors of endothelin receptors
06/07/2012US20120144504 Caspase-8 and skin disease
06/07/2012US20120143805 Cancer Biomarkers and Uses Thereof
06/07/2012US20120142753 Diagnosis and treatment of adrenocortical tumors using human microrna-483
06/07/2012US20120142624 Akt phosphorylation at ser473 as an indicator for taxane-based chemotherapy
06/07/2012US20120142623 Compositions And Methods For Predicting Inhibitors Of Protein Targets
06/07/2012US20120142556 High throughput assays for determining contractile function and devices for use therein
06/07/2012US20120142555 Compositions And Methods For Immunodominant Antigens of Mycobacterium Tuberculosis
06/07/2012US20120142554 High precision quantitative assay composition and methods of use therefor
06/07/2012US20120142553 Molecular Markers in Kidney Cancer
06/07/2012US20120142552 High-sensitivity assays for pathogen detection using metal-enhanced fluorescence
06/07/2012US20120142551 Methods for Genotyping Selected Polymorphism
06/07/2012US20120142550 Vanin 1 as a Peripheral Blood Oxidative Stress Sensor
06/07/2012US20120142549 Raf gene fusions
06/07/2012US20120142548 Methods and compositions for the diagnosis and prognosis of alzheimer's disease
1 ... 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 ... 114